课题基金 / 基金详情

CORE INFRASTRUCTURE SUPPORT

CORE INFRASTRUCTURE SUPPORT
核心基础设施支持
批准号：
9511679
负责人：
SEEMA KHAN
金额：
$157.57万
依托单位：
NORTHWESTERN UNIVERSITY AT CHICAGO
依托单位国家：
美国
项目类别：
财政年份：
2015
资助国家：
美国
项目状态：
已结题
起止时间：
2015-09-24 至 2017-09-23
来源：
https://reporter.nih.gov/project-details/9511679
关键词：
ClinicalClinical ChemopreventionClinical TrialsConduct Clinical TrialsContractorDataDevelopmentDivision of Cancer PreventionDrug IndustryFundingGuidelinesIndividualMaintenanceMalignant NeoplasmsMolecular TargetMonitorNational Cancer InstituteOutcomePerformancePhasePreventionPreventiveProtocols documentationRequest for ProposalsResearch InfrastructureSafetySiteSpecific qualifier valueTimeVisitcancer preventionclinically relevantdata managementinterestlaboratory experimentmeetingsprevention clinical trialprogramsprotocol development

项目摘要

项目成果

SEEMA KHAN的其他基金

相似基金

相关文献

中文摘要
翻译
美国国家癌症研究所（NCI）癌症预防部（DCP）的0/I/II期癌症预防临床试验项目支持早期临床试验，以快速评估DCP感兴趣的癌症预防剂的临床活性和生物学效应。研究的药剂应包括制药行业自行开发并提供给DCP合作开发的药剂、市售药剂和DCP自行开发的药剂。本任务令的目标是提供核心基础设施，以支持临床试验的进行。
英文摘要
The National Cancer Institute (NCI), Division of Cancer Prevention (DCP) Phase 0/I/II Cancer Prevention Clinical Trials Program supports early clinical trials to rapidly evaluate the clinical activity and biologic effects of cancer preventive agents of interest to DCP. The agents to be studied shall include agents developed by the pharmaceutical industry and provided to DCP for collaborative development, commercially available agents, and agents developed by DCP. The objectives of this Task Order are to provide the core infrastructure to support the conduct of the clinical trials.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CONTRACT TITLE - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
CONTRACT TITLE - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
海外基金